Brief: Celldex Reports Third Quarter 2022 Financial Results
Nov 9 (Reuters) - Celldex Therapeutics Inc CLDX.O :
* CELLDEX REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
* Q3 REVENUE $400,000
* Q3 LOSS PER SHARE $0.57
* TOTAL REVENUE WAS $0.4 MILLION IN Q3 OF 2022 COMPARED TO
$0.2
MILLION
* Q3 EARNINGS PER SHARE VIEW $-0.58, REVENUE VIEW $360000.00
--
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6KDzPp
Further company coverage: CLDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celldex Therapeutics
See all newsUS RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Celldex shares slip as safety concerns cloud skin drug trial win (updated)
Celldex falls after two probable anaphylaxis cases in trials
Celldex's skin disease drug meets goals in two late-stage trials